Pomegranate: A 3-year cardiovascular study that no other fruit has replicated episode artwork

EPISODE · May 2, 2026 · 6 MIN

Pomegranate: A 3-year cardiovascular study that no other fruit has replicated

from NutraSift: The nutraceutical innovation podcast · host Siftlink SA

A landmark trial showed pomegranate juice reduced carotid artery intima-media thickness by 30% over 3 years. Long-term arterial regression studies are extraordinarily rare for any intervention drug or natural. No other fruit or botanical has replicated this duration and endpoint. It remains one of the most impressive cardiovascular findings for a food ingredient.Publications of interest:https://pubmed.ncbi.nlm.nih.gov/15158307/https://pubmed.ncbi.nlm.nih.gov/19766760/https://pmc.ncbi.nlm.nih.gov/articles/PMC3514854/

Episode metadata supplied by the publisher feed · Published May 2, 2026

Embed this episode

NOW PLAYING

Pomegranate: A 3-year cardiovascular study that no other fruit has replicated

0:00 6:56

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of NutraSift: The nutraceutical innovation podcast?

This episode is 6 minutes long.

When was this NutraSift: The nutraceutical innovation podcast episode published?

This episode was published on May 2, 2026.

Can I download this NutraSift: The nutraceutical innovation podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!